Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Role of Molecular or Cytogenetic Response as a Favorable Prognostic Factor Before Hematopoietic Stem Cell Transplantation for Chronic Myeloid Leukemia.
Medeiros GRO, Funke VAM, Lima ACM, Mion ALV, Menezes I, Setubal DC, Sola CBDS, Tagliari G, Marchesini R, Nabhan SK, Pasquini R. Medeiros GRO, et al. Among authors: pasquini r. Transplant Cell Ther. 2024 Mar 23:S2666-6367(24)00293-8. doi: 10.1016/j.jtct.2024.03.020. Online ahead of print. Transplant Cell Ther. 2024. PMID: 38522578
Donor-Specific HLA Antibodies Are Associated with Graft Failure and Delayed Hematologic Recovery after Unrelated Donor Hematopoietic Cell Transplantation.
Lima ACM, Getz J, do Amaral GB, Loth G, Funke VAM, Nabhan SK, Petterle RR, de Marco R, Gerbase-DeLima M, Pereira NF, Bonfim C, Pasquini R. Lima ACM, et al. Among authors: pasquini r. Transplant Cell Ther. 2023 Aug;29(8):493.e1-493.e10. doi: 10.1016/j.jtct.2023.05.014. Epub 2023 May 21. Transplant Cell Ther. 2023. PMID: 37220839
The challenge of long-term follow-up of survivors of childhood acute leukemia after hematopoietic stem cell transplantation in resource-limited countries: A single-center report from Brazil.
Marinho DH, Ribeiro LL, Nichele S, Loth G, Koliski A, Mousquer RTG, Funke VAM, Page K, Fasth A, Pasquini R, Boguszewski MCDS, Bonfim C. Marinho DH, et al. Among authors: pasquini r. Pediatr Transplant. 2020 Jun;24(4):e13691. doi: 10.1111/petr.13691. Epub 2020 Apr 4. Pediatr Transplant. 2020. PMID: 32246550
Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia.
Arcuri LJ, Nabhan SK, Cunha R, Nichele S, Ribeiro AAF, Fernandes JF, Daudt LE, Rodrigues ALM, Arrais-Rodrigues C, Seber A, Atta EH, de Oliveira JSR, Funke VAM, Loth G, Junior LGD, Paz A, Calixto RF, Gomes AA, Araujo CES, Colturato V, Simoes BP, Hamerschlak N, Flowers ME, Pasquini R, Rocha V, Bonfim C. Arcuri LJ, et al. Among authors: pasquini r. Biol Blood Marrow Transplant. 2020 Dec;26(12):2311-2317. doi: 10.1016/j.bbmt.2020.09.007. Epub 2020 Sep 17. Biol Blood Marrow Transplant. 2020. PMID: 32949751 Free article.
The impact of donor-specific anti-human leukocyte antigen antibodies in salvage haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide in patients with nonmalignant disorders.
Lima ACM, Bonfim C, Getz J, Dornelles LN, do Amaral GB, Petterle RR, Loth G, Nabhan SK, Pereira NF, Pasquini R. Lima ACM, et al. Among authors: pasquini r. HLA. 2021 Jun;97(6):493-504. doi: 10.1111/tan.14277. Epub 2021 May 2. HLA. 2021. PMID: 33886161
Transplantation for Fanconi anaemia: lessons learned from Brazil.
Bonfim C, Nichele S, Loth G, Funke VAM, Nabhan SK, Pillonetto DV, Lima ACM, Pasquini R. Bonfim C, et al. Among authors: pasquini r. Lancet Haematol. 2022 Mar;9(3):e228-e236. doi: 10.1016/S2352-3026(22)00032-1. Lancet Haematol. 2022. PMID: 35240077 Review.
233 results